47 results about "Injections insulin" patented technology

Methods and associated devices for establishing basal rates to be programmed into a diabetic pump that periodically administers insulin to a patient. The instant disclosure also includes diabetic pumps programmed in accordance with the instant disclosure.

The utility model belongs to insulin pen needle field, specifically comfortable big plane insulin pen needle, including outer needle cap, the inner chamber fixed connection of outer needle cap has pen needle body, the top of outer needle cap is provided with expansion mechanism, the utility model discloses a rotation ring piece, makes rotation ring piece to be able to smoothly pass through the extension block that is pulled to the rotary plate and the rotating rod, the extension block can smoothly with the center of the mounting rod circle as the center, to the center of the fixed ring piece's one side that is far away from rotating, further in the rotation to certain distance after, through the contact of self and people's skin, increase the stability of pen needle body when using, reached when pen needle body is inserted to people's body inside, pen needle body is not easy when injecting insulin, take place big amplitude's shake or shake, thereby reduced because pen needle body is not enough stable when using self, and increased people's painful feeling condition, increased the comfortable feeling of pen needle body when using.

The invention discloses an insulin sterile injection device for diabetics in the field of insulin injection, which comprises two mounting frames, side brackets are arranged at the upper parts of the sides close to each other, and a middle bracket is arranged between the two side brackets; the left end and the right end of the middle support are connected with the corresponding side supports through height adjusting assemblies respectively, a moving seat capable of moving transversely is arranged on the middle support, an injection positioning mechanism capable of swinging front and back is arranged on the moving seat, and an injector is installed on the injection positioning mechanism. A plurality of transverse connecting belts are connected to the outer sides of the two mounting frames, the outward end of each connecting belt on the left side is fixed to the first fixing part, and the outward end of each connecting belt on the right side is fixed to the second fixing part. The sterile insulin injection device can achieve sterile insulin injection, and injection part infection caused by nonstandard operation is avoided.

The utility model provides a medicine storage device structure of an insulin pump for the endocrinology department, which belongs to the technical field of medical instruments and comprises a medicine storage device main body, a first milliliter scale is engraved in the center of the outer side surface of the medicine storage device main body; insulin is stored through the medicine storage device main body, the insulin operation required by quantitative extraction before insulin injection is not needed, and the positioning bolt is screwed into the corresponding bolt hole, so that the positioning bolt is attached to the bottom surface of the cross rod, the push rod and the piston are prevented from moving upwards, and the insulin is prevented from being discharged from the liquid discharge connector due to misoperation. When insulin is injected, the positioning bolt is loosened, the upward moving distance of the piston is determined according to the first milliliter scale and the second milliliter scale, then the positioning bolt is screwed into the corresponding bolt hole, the ascending distance of the push rod and the piston is limited, and the effect that the insulin in the medicine storage device body is quantitatively injected into an insulin pump is achieved. And the situation that too much insulin is added due to misoperation of medical staff is prevented.

The utility model discloses a portable insulin preservation cup which is characterized in that an inner ring is fixedly installed in a cup body, a biological ice bag is arranged between the inner ring and the cup body, a fixing seat is fixedly arranged on the inner wall of the inner ring, and the side, away from the inner ring, of the fixing seat is used for storing insulin; the pressing rod is slidably inserted into the fixing base, telescopic blocks are arranged on the two sides of the pressing rod, and a fixing plate is fixedly installed on the surfaces of the telescopic blocks. The support rod is inserted into one side, far away from the inner ring, of the fixed seat; the fixing plate and the supporting rod are arranged in the cup body, after insulin is placed in the cup body, the insulin is fixed through the fixing plate and the supporting rod, insulin damage caused by shaking in the carrying process is avoided, the biological ice bag is placed between the cup body and the inner ring, a low-temperature storage space is formed in the cup body, and the insulin is stored in the low-temperature storage space. Meanwhile, the insulin injection device is convenient to carry when a patient goes out, and the problem that the insulin cannot be injected in time when the patient goes out is solved.

1. Name of the Design Product: Syringe. 2. Use of the Design Product: For example, for diabetics to inject insulin by themselves, etc. 3. Design Key Points of the Design Product: Lies in the overall shape and structure. 4. Picture or Photograph that Best Illustrates the Design Key Points: Perspective View 1.

The invention discloses a rotary insulin abdominal injection alternate positioning card, which comprises a fixed plate, a rotating plate, a rotating assembly, a spirit bubble, an injection assembly, a locking assembly, a screw rod and a reminding assembly, the rotating plate is arranged in the fixed plate, the rotating assembly is arranged below the rotating plate, the rotating plate is connected with the fixed plate through the rotating assembly, and the locking assembly is arranged below the screw rod. The spirit bubble is transversely connected into a groove preset in the top of the fixed plate, the injection assembly is slidably connected to one side of the rotating plate, the multiple locking assemblies are arranged in the fixed plate and connected with the rotating plate, and the lead screw is rotationally arranged on one side of the injection assembly and connected with the injection assembly. According to the insulin injection device, in the process that a patient injects insulin or a needle needs to stay under the skin after injection is completed, the injection assembly can clamp a needle cylinder, so that the needle is fixed, and the situations that the needle shakes during injection and falls off from the skin are avoided.

1. The name of the product of this design: insulin injection pen. 2. Purpose of the product of this design: device for injecting insulin. 3. The design key point of this appearance design product lies in the shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.

The application discloses a kind of sterile insulin injection devices for diabetic patients in the field of insulin injection, including two the installation frame mutually close one side upper portion It is provided with side support on each, it is provided with middle support between two side supports, the left and right ends of the middle support are connected with corresponding side support respectively via a height adjusting assembly, it is provided with the movable seat that can move transversely on the middle support, it is provided with the injection positioning mechanism that can swing position forward and backward on the movable seat, the injector is installed on the injection positioning mechanism;The outside of two the installation frame is connected with several transverse coupling belts, the outward end of each coupling belt on left side is fixed with fixed part one, the outward end of each coupling belt on right side is fixed with fixed part two.The application can realize sterile insulin injection, avoid the infection of injection site caused by non-standard operation.

The invention relates to the technical field of medical instruments, in particular to a memory alloy pump and an insulin pump system thereof. The memory alloy pump comprises an upper shell, a lower shell, a memory alloy wire and a power supply; according to the principle that the length of the memory alloy wire is shortened when the memory alloy wire is electrified, power for pushing liquid medicine downwards is provided for the memory alloy pump, and the memory alloy pump is small in size, simple in structure and convenient to carry. The insulin pump system comprises a liquid storage structure, a memory alloy pump, an infusion structure and a micro-processing unit; the micro-processing unit comprises a calculation subunit and a control subunit, the calculation subunit can calculate the power-on time of the memory alloy pump according to input human body blood sugar data and send the power-on time to the control subunit, and the control subunit controls the pump to be powered on according to the power-on time. The purpose of automatically and quantitatively injecting insulin according to the requirement of a patient for insulin is achieved, and the problem that an existing insulin pump cannot automatically inject insulin according to the blood sugar content of a human body is solved.

1. The name of the design product: insulin pump. 2. The use of the design product: for patients to inject insulin. 3. The design features of the design product: in shape. 4. The picture or photo that best shows the design features: perspective view.

The invention relates to a hypodermic injection insulin system automatic dose recommendation method based on a big data AI algorithm, and the method comprises the following steps: (1) adding a current patient to a hypodermic injection insulin system for information setting; (2) calculating the initial daily total dose TDD of insulin needing to be injected by the patient at present; (3) calculating a correction large-dose coefficient CF of the insulin to be injected; (4) collecting the blood glucose value of the patient in the current state, and further calculating an adjustment factor AF; and (5) comparing the currently collected blood glucose value of the patient with a preset threshold value to prevent the occurrence of hypoglycemia. By adopting the automatic dose recommendation method for the subcutaneous injection insulin system based on the big data AI algorithm, the probability of occurrence of hypoglycemia can be effectively reduced by 97% or above, so that the time of reaching the blood glucose standard of a patient is saved by 34% or above, and the method has certain practicability in the aspects of reducing the hospitalization time of the patient and the like.

Described herein are examples of systems and methods for determining the efficacy of a therapeutic intervention related to the treatment of diabetes. In an example, a continuous glucose monitor can be used to monitor the glucose levels of a subject. An insulin pump can administer insulin to the subject in response to the glucose levels obtained by the continuous glucose monitor. The efficacy of a treatment intervention can be determined by comparing an amount of insulin administered to the subject by the insulin pump over a timeframe associated with the treatment intervention to an amount of insulin administered to the subject by the insulin pump over a timeframe associated with a control or placebo period and / or a timeframe associated with a second treatment intervention.

Systems and methods are disclosed for managing a person's blood glucose concentration within a predetermined range by co-administration of insulin and pramlintide using an automated insulin delivery system. A model predictive control (MPC) algorithm that includes a glucoregulatory control model augmented with a compartment model of pramlintide pharmacokinetics and pharmacodynamics is utilized. In some embodiments, the person may announce in advance meals to be consumed and the pramlintide-aware MPC algorithm uses this data as input to the glucoregulatory control model. In other embodiments, an automatic meal detection and size estimation algorithm is incorporated into the system to relieve the person of the burden of meal entry and carbohydrate estimation.

The present application relates to the technical field of insulin injection, in particular to a moon phase insulin syringe, which comprises a syringe body, a protective cover, a connecting chuck, a connecting clasp, a connecting ring, a connecting threaded ring, a connecting threaded groove, a connecting head and a needle, the connecting chuck is fixedly connected at the bottom of the syringe body, the connecting clasp is fixedly connected at the bottom end of the connecting chuck, the protective cover is clamped and fixedly connected at the bottom end of the connecting chuck through the connecting clasp, the connecting threaded ring is fixedly connected at the middle of the bottom end of the syringe body, the connecting ring is fixedly connected at the bottom end of the connecting chuck, the connecting threaded ring is located inside the connecting ring, and the connecting threaded groove is arranged between the connecting threaded ring and the connecting ring. The connecting adjusting part and the stamping part can leave a decorative pattern around the injection needle hole during the process of inserting the needle into the skin to inject insulin, the pattern can shield the needle hole, and the position and the number of needle pricking can be known by observing the pattern.

1. Name of the design product: Emergency syringe. 2. Use of the design product: This design product is used for injecting drugs such as insulin. 3. Design key points of the design product: Lies in the shape. 4. Picture or photo that best shows the design key points: Perspective view 1.

1. The name of the product of this design: Insulin pump (for endocrinology only). 2. Purpose of the product with this design: The product with this design is used for patients to inject insulin. 3. The design key point of this appearance design product lies in the shape of the product. 4. The picture or photo that best illustrates the design points: three-dimensional picture.

A method, system, and computer-readable medium are provided for a dual mode Closed-Loop Control (CLC) system integrating each of (i) an adaptive, personalized Model Predictive Control (MPC) control law that modulates the control strength of insulin infusion depending on recent past control actions, glucose measurements, and their derivative(s), (ii) an automatic Bolus Priming System (BPS) that commands additional insulin injections upon the detection of enabling metabolic conditions (e.g., an unannounced meal), and (iii) a hyperglycemia mitigation system (HMS) to avoid prevailing hyperglycemia.

The invention relates to the technical field of medical auxiliary equipment, and discloses an insulin injection intelligent prompt card assembly which comprises a prompt card body, the right surface of the prompt card body is fixedly connected with a bandage body, and the left surface of the bandage body is fixedly connected with a cylindrical limiting block. The left surface of the prompt card body is fixedly connected with a fixing mechanism, the fixing mechanism comprises a fixing block, the fixing block is fixedly connected with the prompt card body, the upper surface of the fixing block is provided with a groove, and the inner surface of the groove is slidably connected with a cylindrical limiting block; according to the insulin injection intelligent prompt card assembly, by means of the arrangement of the cylindrical limiting block, the fixed block, the plug pin and the movable block, the cylindrical limiting block is inserted into the fixed block, and meanwhile the plug pin and the movable block are matched to limit the cylindrical limiting block; the prompt card body can be tightly attached to the bellies of patients with different figures, and insulin injection is facilitated.

To support patient management by predicting changes in blood sugar levels of a diabetic patient and notifying a user of an insulin injection at an appropriate timing.SOLUTION: A system includes a wearable device including AI for predicting changes in blood sugar levels, means for automatically notifying a user of a timing of an insulin injection, and means for notifying a user and a contact address when hypoglycemia is detected.SELECTED DRAWING: Figure 1

1. Name of the product under this design: syringe. 2. Purpose of this design product: This design product is a syringe for injecting insulin. 3. The key point of the design of this product lies in its shape. 4. The picture or photo that best illustrates the design points: Stereoscopic drawing 1.

Methods and associated devices for establishing basal rates to be programmed into a diabetic pump that periodically administers insulin to a patient. The instant disclosure also includes diabetic pumps programmed in accordance with the instant disclosure.

The utility model relates to the technical field of medical treatment, and discloses a portable insulin seal film which comprises a shell, and a positioning assembly is arranged on the inner wall of the shell. According to the portable insulin seal film, the wheel disc body is tightly attached to the skin through the bonding layer, when a patient needs to inject insulin, the patient is aligned with the hip wheel disc with the corresponding number, after injection is completed, the first uncovering piece of the corresponding hip wheel disc is uncovered, and then positioning injection of the insulin is completed; according to the seal film, water drops can only make contact with the vertex angles of the wax-shaped protrusions, so that the water drops cannot stay on the surface of the wheel disc body for a long time, and a patient does not need to worry about falling off of the seal film body while taking a bath or swimming under the condition that the seal film body is worn; when a patient needs to inject insulin, a proper wheel disc can be selected according to needs, and more choices and convenience are provided.

1. Name of the product in this design: Insulin Pump. 2. Purpose of this design: For use in injecting insulin into patients. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D rendering 2.

1. Name of the product in this design: Insulin Pump (Endocrine). 2. Purpose of this design: For use in insulin injection. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D view 1.

The invention discloses a method and equipment for optimizing the initial four-time injection dosage of a weekly insulin preparation, and the method comprises the steps: obtaining corresponding information used for calculating the first injection dosage W1 before the first injection of the weekly insulin preparation; determining W1 according to the acquired corresponding information; determining a second injection regulation coefficient k2 and a second injection dosage W2 according to the fasting blood glucose gear and W1 after the first injection of the periinsulin preparation and before the second injection of the periinsulin preparation; determining a third injection regulation coefficient k3 and a third injection dosage W3 according to fasting blood glucose gears, W1, k2 and W2 after the second injection of the periinsulin preparation and before the third injection of the periinsulin preparation; and determining a third injection regulation coefficient k4 and a third injection dosage W4 according to fasting blood glucose gears, W1, k2, W2, k3 and W3 after the third injection of the periinsulin preparation and before the fourth injection of the periinsulin preparation. According to the invention, a more scientific basis can be provided for the initial four-time injection dosage of the weekly preparation.

1. Name of the designed product: needleless injector (2). 2. Use of the designed product: for injecting insulin or growth hormone. 3. Design points of the designed product: in shape. 4. Picture or photo best indicating the design points: perspective view 1.

The utility model relates to the technical field of insulin injection, and discloses an insulin injection device which comprises a protection assembly. The protection assembly comprises an insulin syringe, a needle head and a needle head, the needle cap is sleeved on the needle head; the mounting ring is arranged on the insulin syringe; the mounting groove is formed in the outer side of the mounting ring; the frame body is hinged to the inner side of the mounting groove; the movable plate is connected to the inner side of the frame body in a sleeving manner; according to the insulin injection device, the frame body is lifted, then a medical worker takes down the needle cap, then the needle cap is taken down so that insulin can be injected to a patient, the frame body is reset after use, the needle head is sleeved with the check block, and therefore when the needle cap is sleeved back, the needle cap can be reset only by inserting the needle cap into the inner side of the through groove; therefore, the medical staff can be prevented from directly contacting with the needle head, the medical staff can be prevented from being punctured by the needle, the medical staff can be effectively prevented from being infected, hematogenous infectious diseases caused by infection can be effectively avoided, and the safety is improved.

The positioning disc comprises a flexible positioning disc, a navel positioning hole is formed in the center of the flexible positioning disc, and a plurality of injection positioning holes distributed circumferentially are formed in the edge of the flexible positioning disc. A hole covering patch with one face provided with glue is pasted to the position, at each injection positioning hole, of the upper end of the flexible positioning disc, a plurality of flexible connecting pieces are arranged on the edge of the flexible positioning disc, a plurality of suction cups are arranged at the lower end of each flexible connecting piece, and an elastic negative-pressure flat tube is arranged at the upper end of each flexible connecting piece. Each suction cup is communicated with the corresponding negative-pressure flat tube, a one-way valve is arranged at the upper end of each negative-pressure flat tube, and each one-way valve is opened towards the interior of the negative-pressure flat tube, and is closed on the contrary. The flexible positioning disc is attached to the abdomen of a patient, insulin is injected from the injection positioning hole, one hole covering patch needs to be torn off during each injection, and repeated position injection can be effectively avoided.

The utility model relates to an insulin pen needle head which comprises a needle shell, a needle head body and a needle sleeve, the end of the needle shell is communicated with the needle head body, the needle sleeve is arranged on the needle shell and used for covering the needle head body, sterile sponge is filled in the needle sleeve, a containing cavity is formed in the needle sleeve, an alcohol capsule is placed in the containing cavity, and a plurality of through holes are formed in the connecting position of the needle sleeve and the containing cavity. And the placing cavity is made of a soft material. Before insulin is injected, a patient firstly enables the end, away from the needle head body, of the needle shell to be communicated with an insulin pen, then extrudes the alcohol capsule to enable disinfection alcohol to flow into the sterile sponge in the needle sleeve through the through hole, then the needle shell and the needle sleeve are separated, and the sterile sponge containing the alcohol in the needle shell is taken out to disinfect an injection part. The insulin pen needle head is provided with the alcohol and the sterile sponge, so that the situation that a patient forgets to carry disinfection articles and injects without proper disinfection can be effectively avoided, and the infection risk of an injection part is reduced.